Current guidelines poorly address multimorbidity: Pilot of the interaction matrix method

Journal of Clinical Epidemiology

Volumn 67, Issue 11, 2014, Pages 1242-1250

  Muth, Christiane ^a   Kirchner, Hanna ^a,b   Van Den Akker, Marjan ^c,d   Scherer, Martin ^b   Glasziou, Paul P ^e  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e BOND UNIVERSITY   (Australia)

Author keywords

Comorbidity MeSH ; Drug interactions MeSH ; Heart failure MeSH ; Interactions; Multimorbidity; Practice guideline MeSH

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COUGHING; DEPRESSION; DRUG CONTRAINDICATION; DRUG INTERACTION; EVIDENCE BASED PRACTICE; EYE DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; HYPERTHYROIDISM; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; PRACTICE GUIDELINE; CHRONIC DISEASE; DECISION MAKING; DISEASE MANAGEMENT; REPRODUCIBILITY; STANDARDS;

CHRONIC DISEASE; COMORBIDITY; DECISION MAKING; DISEASE MANAGEMENT; DRUG INTERACTIONS; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 84908248517     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2014.07.004     Document Type: Article

References (37)

1. M. Komajda, P. Lapuerta, N. Hermans, J.R. Gonzalez-Juanatey, D.J. van Veldhuisen, and E. Erdmann Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur Heart J 26 2005 1653 1659
2. M. Lugtenberg, J.S. Burgers, and G.P. Westert Effects of evidence-based clinical practice guidelines on quality of care: a systematic review Qual Saf Health Care 18 2009 385 392
3. M. Fortin, E. Contant, C. Savard, C. Hudon, M.E. Poitras, and J. Almirall Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity BMC Fam Pract 12 2011 74
4. A.I. Vitry, and Y. Zhang Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions Med J Aust 189 2008 360 365
5. M. van den Akker, F. Buntinx, and J. Knottnerus Comorbidity or multimorbidity: what's in a name. A review of literature Eur J Gen Pract 2 1996 65 70
6. C.M. Boyd, J. Darer, C. Boult, L.P. Fried, L. Boult, and A.W. Wu Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance JAMA 294 2005 716 724
7. H.D. Luijks, M.J. Loeffen, A.L. Lagro-Janssen, W.C. van, P.L. Lucassen, and T.R. Schermer GPs' considerations in multimorbidity management: a qualitative study Br J Gen Pract 62 2012 503 510
8. Koordination und Integration - Gesundheitsversorgung in einer Gesellschaft des längeren Lebens Available at http://www.svr-gesundheit.de/index.php?id=14. Accessed September 10, 2014.
9. E. Blozik, B.H. van den, F. Gurtner, I. Schafer, and M. Scherer Epidemiological strategies for adapting clinical practice guidelines to the needs of multimorbid patients BMC Health Serv Res 13 2013 352
10. L.M. Fabbri, C. Boyd, P. Boschetto, K.F. Rabe, A.S. Buist, and B. Yawn How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report Proc Am Thorac Soc 9 2012 274 281
11. B. Guthrie, K. Payne, P. Alderson, M.E. McMurdo, and S.W. Mercer Adapting clinical guidelines to take account of multimorbidity BMJ 345 2012 e6341
12. K. Uhlig, B. Leff, D. Kent, S. Dy, K. Brunnhuber, and J.S. Burgers A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity J Gen Intern Med 29 2014 670 679
13. S.C. Ahluwalia, C.P. Gross, S.I. Chaudhry, L. Leo-Summers, P.H. Van Ness, and T.R. Fried Change in comorbidity prevalence with advancing age among persons with heart failure J Gen Intern Med 26 2011 1145 1151
14. J.B. Braunstein, G.F. Anderson, G. Gerstenblith, W. Weller, M. Niefeld, and R. Herbert Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 2003 1226 1233
15. M. Carmona, L.M. Garcia-Olmos, A. Alberquilla, A. Munoz, P. Garcia-Sagredo, and R. Somolinos Heart failure in the family practice: a study of the prevalence and co-morbidity Fam Pract 28 2011 128 133
16. V. Mastromarino, M. Casenghi, M. Testa, E. Gabriele, R. Coluccia, and S. Rubattu Polypharmacy in heart failure patients Curr Heart Fail Rep 11 2014 212 219
17. B. Straubhaar, S. Krahenbuhl, and R.G. Schlienger The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge Drug Saf 29 2006 79 90
18. G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom, T.K. Schramm, M.L. Hansen, and E.L. Fosbol Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure Arch Intern Med 169 2009 141 149
19. S.R. Salpeter, T.M. Ormiston, E.E. Salpeter, P.J. Poole, and C.J. Cates Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis (Brief record) Respir Med 97 2003 1094 1101
20. R.H. Browne On the use of a pilot sample for sample size determination Stat Med 14 1995 1933 1940
21. G.A. Lancaster, S. Dodd, and P.R. Williamson Design and analysis of pilot studies: recommendations for good practice J Eval Clin Pract 10 2004 307 312
22. K.A. Hallgren Computing inter-rater reliability for observational data: an overview and tutorial Tutor Quant Methods Psychol 8 2012 23 34
23. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
24. L. Hartling, M. Ospina, Y. Liang, D.M. Dryden, N. Hooton, and J. Krebs Seida Risk of bias versus quality assessment of randomised controlled trials: cross sectional study BMJ 339 2009 b4012
25. M. Lugtenberg, J.S. Burgers, C. Clancy, G.P. Westert, and E.C. Schneider Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines PLoS One 6 2011 e25987
26. G.E. Caughey, E.E. Roughead, S. Shakib, A.I. Vitry, and A.L. Gilbert Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data Drugs Aging 28 2011 575 581
27. S.H. van Oostrom, H.S. Picavet, B.M. van Gelder, L.C. Lemmens, N. Hoeymans, and R.A. Verheij Multimorbidity and comorbidity in the Dutch population - data from general practices] [Article in Dutch Ned Tijdschr Geneeskd 155 2011 A3193
28. C.Y. Wong, S.I. Chaudhry, M.M. Desai, and H.M. Krumholz Trends in comorbidity, disability, and polypharmacy in heart failure Am J Med 124 2011 136 143
29. M. Fortin, M. Stewart, M.E. Poitras, J. Almirall, and H. Maddocks A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology Ann Fam Med 10 2012 142 151
30. F. Lapi, L. Azoulay, H. Yin, S.J. Nessim, and S. Suissa Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study BMJ 346 2013 e8525
31. K.K. Loboz, and G.M. Shenfield Drug combinations and impaired renal function - the 'triple whammy' Br J Clin Pharmacol 59 2005 239 243
32. C. Muth, J. Gensichen, M. Beyer, A. Hutchinson, and F.M. Gerlach The systematic guideline review: method, rationale, and test on chronic heart failure BMC Health Serv Res 9 2009 74
33. A. Marengoni, S. Angleman, R. Melis, F. Mangialasche, A. Karp, and A. Garmen Aging with multimorbidity: a systematic review of the literature Ageing Res Rev 10 2011 430 439
34. M. van den Akker, F. Buntinx, J.F. Metsemakers, S. Roos, and J.A. Knottnerus Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases J Clin Epidemiol 51 1998 367 375
35. M. Lappenschaar, A. Hommersom, P.J. Lucas, J. Lagro, S. Visscher, and J.C. Korevaar Multilevel temporal Bayesian networks can model longitudinal change in multimorbidity J Clin Epidemiol 66 2013 1405 1416
36. A. Prados-Torres, A. Calderon-Larranaga, J. Hancco-Saavedra, B. Poblador-Plou, and A.M. van den Multimorbidity patterns: a systematic review J Clin Epidemiol 67 2014 254 266
37. H. van den Bussche, I. Schafer, B. Wiese, A. Dahlhaus, A. Fuchs, and J. Gensichen A comparative study demonstrated that prevalence figures on multimorbidity require cautious interpretation when drawn from a single database J Clin Epidemiol 66 2013 209 217